Cetya Therapeutics

Share on: 
Business Area(s): 
Description: 

Cetya Therapeutics, Inc. is working to develop histone deacetylase inhibitors (HDACi) based on analogs of largazole. Some of these analogs incorporate receptor ligands, which enable them to target specific cell types or tumors.

Location(s): 
Fort Collins CO
United States